Analyzing Generics Market in South Africa 2017
The South African generics industry has been growing at a substantial rate in recent years. It can be said that the pharmaceutical industry has become one of the fastest growing industries in the world. Amongst this, South Africa remains a clear market leader with a booming market for generics.
The South African government has been pushing for the growth of the generics market and it has led to a lot of development within this particular segment. The country is also undergoing a change in its regulatory framework to support the growth of the pharmaceutical industry as well as introducing a progressive law for intellectual property that would favor generic drugs.
Aruvian Research presents Analyzing Generics Market in South Africa 2017 – a comprehensive coverage of the South African generic drugs market. Beginning with a sectional description on the global generic industry, the report looks at an overview of the industry, an analysis of the market volume and value, industry segmentation and an industry forecast.
The Generics Industry in South Africa is analyzed through an industry overview which spans the data from 2012 till 2021. An analysis of the industry's value and volume data is included along with an industry segmentation by geography. Industry forecast of the industry is also included.
We also include a Porter’s Five Forces analysis of the South African Generics Industry.
Analysis of the major industry players in the South African generics market are analyzed through an analysis of their business segments, a financial analysis and a SWOT analysis. Players analyzed include Adcock Ingram, Cipla Limited, Aspen Pharmacare and Teva Pharmaceutical Industries. This concludes this comprehensive research report from Aruvian Research.
The South African government has been pushing for the growth of the generics market and it has led to a lot of development within this particular segment. The country is also undergoing a change in its regulatory framework to support the growth of the pharmaceutical industry as well as introducing a progressive law for intellectual property that would favor generic drugs.
Aruvian Research presents Analyzing Generics Market in South Africa 2017 – a comprehensive coverage of the South African generic drugs market. Beginning with a sectional description on the global generic industry, the report looks at an overview of the industry, an analysis of the market volume and value, industry segmentation and an industry forecast.
The Generics Industry in South Africa is analyzed through an industry overview which spans the data from 2012 till 2021. An analysis of the industry's value and volume data is included along with an industry segmentation by geography. Industry forecast of the industry is also included.
We also include a Porter’s Five Forces analysis of the South African Generics Industry.
Analysis of the major industry players in the South African generics market are analyzed through an analysis of their business segments, a financial analysis and a SWOT analysis. Players analyzed include Adcock Ingram, Cipla Limited, Aspen Pharmacare and Teva Pharmaceutical Industries. This concludes this comprehensive research report from Aruvian Research.
A. EXECUTIVE SUMMARY
B. ANALYZING THE GLOBAL GENERICS INDUSTRY
B.1 Industry Definition
B.2 Industry Overview
B.3 Industry Value & Volume Analysis
B.4 Industry Segmentation by Geography
B.5 Patent Expiries
B.6 Global Generic Industry Structure
B.7 Industry Forecast
C. GENERICS INDUSTRY IN SOUTH AFRICA
C.1 Industry Overview
C.2 Industry Value & Volume
C.3 Industry Segmentation by Geography
C.4 Industry Forecast
D. GENERICS INDUSTRY IN SOUTH AFRICA: PORTER’S FIVE FORCES STRATEGY ANALYSIS
D.1 Introduction
D.2 Bargaining Power of Buyers
D.3 Bargaining Power of Suppliers
D.4 Competitive Rivalry in the Industry
D.5 Threat of New Entrants
D.6 Threat of Substitutes
E. MAJOR INDUSTRY PLAYERS
E.1 Aspen Pharmacare Holdings Ltd
E.1.1 Corporate Analysis
E.1.2 Financial Analysis
E.1.3 SWOT Analysis
E.2 Cipla Limited
E.2.1 Corporate Analysis
E.2.2 Financial Analysis
E.2.3 SWOT Analysis
E.3 Sanofi SA
E.3.1 Corporate Analysis
E.3.2 Financial Analysis
E.3.3 SWOT Analysis
E.4 Teva Pharmaceutical Industries Limited
E.4.1 Corporate Analysis
E.4.2 Financial Analysis
E.4.3 SWOT Analysis
E.5 Adcock Ingram Holdings Limited
E.6 Sun Pharmaceutical Industries Ltd.
F. GLOSSARY OF TERMS
B. ANALYZING THE GLOBAL GENERICS INDUSTRY
B.1 Industry Definition
B.2 Industry Overview
B.3 Industry Value & Volume Analysis
B.4 Industry Segmentation by Geography
B.5 Patent Expiries
B.6 Global Generic Industry Structure
B.7 Industry Forecast
C. GENERICS INDUSTRY IN SOUTH AFRICA
C.1 Industry Overview
C.2 Industry Value & Volume
C.3 Industry Segmentation by Geography
C.4 Industry Forecast
D. GENERICS INDUSTRY IN SOUTH AFRICA: PORTER’S FIVE FORCES STRATEGY ANALYSIS
D.1 Introduction
D.2 Bargaining Power of Buyers
D.3 Bargaining Power of Suppliers
D.4 Competitive Rivalry in the Industry
D.5 Threat of New Entrants
D.6 Threat of Substitutes
E. MAJOR INDUSTRY PLAYERS
E.1 Aspen Pharmacare Holdings Ltd
E.1.1 Corporate Analysis
E.1.2 Financial Analysis
E.1.3 SWOT Analysis
E.2 Cipla Limited
E.2.1 Corporate Analysis
E.2.2 Financial Analysis
E.2.3 SWOT Analysis
E.3 Sanofi SA
E.3.1 Corporate Analysis
E.3.2 Financial Analysis
E.3.3 SWOT Analysis
E.4 Teva Pharmaceutical Industries Limited
E.4.1 Corporate Analysis
E.4.2 Financial Analysis
E.4.3 SWOT Analysis
E.5 Adcock Ingram Holdings Limited
E.6 Sun Pharmaceutical Industries Ltd.
F. GLOSSARY OF TERMS
LIST OF FIGURES
Figure 1: Historical Revenues of Leading Generic Companies (in USD Million), 2008-2009
Figure 2: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
Figure 3: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
Figure 4: Global Generics Market Segmentation by Geography (%), 2016
Figure 5: Revenues of Top 10 Drugs that went off Patent between 2010-2014 (in USD Million)
Figure 6: Market Share of Leading Generic Companies Worldwide (%), 2016
Figure 7: Comparison of Revenues of Leading Generic Companies (in USD Million), 2013-2014
Figure 8: Global Generics Industry Forecast (in USD Billion), 2016-2021
Figure 9: Global Generics Industry Forecast by Volume (% of Pharma Volume), 2016-2021
Figure 10: Value of the Generics Market in South Africa (in USD Billion), 2012-2016
Figure 11: Volume Growth of the Generics Market in South Africa (%), 2012-2016
Figure 12: Share of South Africa in the MEA Generics Industry (%), 2016
Figure 13: Forecast of the Generics Market in South Africa (in USD Billion), 2016-2021
Figure 14: Volume Forecast of the Generics Market in South Africa (%), 2016-2021
Figure 15: Porter's Five Forces Strategy Analysis of the Generics Industry in South Africa
Figure 16: Bargaining Power of Buyers in the South African Generics Industry
Figure 17: Bargaining Power of Suppliers in the South African Generics Industry
Figure 18: Competitive Rivalry in the South African Generics Industry
Figure 19: Threat of New Entrants to the South African Generics Industry
Figure 20: Threat of Substitutes to the South African Generics Industry
Figure 21: Revenues & Profitability of Aspen Pharmacare (in USD Million), 2011-2015
Figure 22: Revenues & Profitability of Cipla Limited (in USD Million), 2011-2015
Figure 23: Revenues & Profitability of Sanofi SA (in USD Million), 2011-2015
Figure 24: Revenues & Profitability of Teva Pharmaceutical (in USD Million), 2011-2015
Figure 25: Revenues & Profitability of Adcock Ingram (in USD Million), 2011-2015
Figure 26: Revenues & Profitability of Sun Pharmaceutical (in USD Million), 2011-2015
Figure 1: Historical Revenues of Leading Generic Companies (in USD Million), 2008-2009
Figure 2: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
Figure 3: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
Figure 4: Global Generics Market Segmentation by Geography (%), 2016
Figure 5: Revenues of Top 10 Drugs that went off Patent between 2010-2014 (in USD Million)
Figure 6: Market Share of Leading Generic Companies Worldwide (%), 2016
Figure 7: Comparison of Revenues of Leading Generic Companies (in USD Million), 2013-2014
Figure 8: Global Generics Industry Forecast (in USD Billion), 2016-2021
Figure 9: Global Generics Industry Forecast by Volume (% of Pharma Volume), 2016-2021
Figure 10: Value of the Generics Market in South Africa (in USD Billion), 2012-2016
Figure 11: Volume Growth of the Generics Market in South Africa (%), 2012-2016
Figure 12: Share of South Africa in the MEA Generics Industry (%), 2016
Figure 13: Forecast of the Generics Market in South Africa (in USD Billion), 2016-2021
Figure 14: Volume Forecast of the Generics Market in South Africa (%), 2016-2021
Figure 15: Porter's Five Forces Strategy Analysis of the Generics Industry in South Africa
Figure 16: Bargaining Power of Buyers in the South African Generics Industry
Figure 17: Bargaining Power of Suppliers in the South African Generics Industry
Figure 18: Competitive Rivalry in the South African Generics Industry
Figure 19: Threat of New Entrants to the South African Generics Industry
Figure 20: Threat of Substitutes to the South African Generics Industry
Figure 21: Revenues & Profitability of Aspen Pharmacare (in USD Million), 2011-2015
Figure 22: Revenues & Profitability of Cipla Limited (in USD Million), 2011-2015
Figure 23: Revenues & Profitability of Sanofi SA (in USD Million), 2011-2015
Figure 24: Revenues & Profitability of Teva Pharmaceutical (in USD Million), 2011-2015
Figure 25: Revenues & Profitability of Adcock Ingram (in USD Million), 2011-2015
Figure 26: Revenues & Profitability of Sun Pharmaceutical (in USD Million), 2011-2015
LIST OF TABLES
Table 1: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
Table 2: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
Table 3: Global Generics Industry, Segmentation by Geography (in USD Billion), 2016
Table 4: Global Generics Industry Forecast (in USD Billion), 2016-2021
Table 5: Global Generics Industry Forecast by Volume & Percentage Growth (% of Pharma Volume), 2016-2021
Table 6: Value of the Generics Market in South Africa (in USD Billion), 2012-2016
Table 7: Volume Growth of the Generics Market in South Africa (%), 2012-2016
Table 8: Share of South Africa in the MEA Generics Industry (in USD Billion & %), 2016
Table 9: Forecast of the Generics Market in South Africa (in USD Billion), 2016-2021
Table 10: Volume Forecast of the Generics Market in South Africa (%), 2016-2021
Table 11: Key Financials of Aspen Pharmacare (in USD Million), 2011-2015
Table 12: Key Financials of Cipla Limited (in USD Million), 2011-2015
Table 13: Key Financials of Sanofi SA (in USD Million), 2011-2015
Table 14: Key Financials of Teva Pharmaceutical (in USD Million), 2011-2015
Table 15: Key Financials of Adcock Ingram (in USD Million), 2011-2015
Table 16: Key Financials of Sun Pharmaceutical (in USD Million), 2011-2015
Table 1: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
Table 2: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
Table 3: Global Generics Industry, Segmentation by Geography (in USD Billion), 2016
Table 4: Global Generics Industry Forecast (in USD Billion), 2016-2021
Table 5: Global Generics Industry Forecast by Volume & Percentage Growth (% of Pharma Volume), 2016-2021
Table 6: Value of the Generics Market in South Africa (in USD Billion), 2012-2016
Table 7: Volume Growth of the Generics Market in South Africa (%), 2012-2016
Table 8: Share of South Africa in the MEA Generics Industry (in USD Billion & %), 2016
Table 9: Forecast of the Generics Market in South Africa (in USD Billion), 2016-2021
Table 10: Volume Forecast of the Generics Market in South Africa (%), 2016-2021
Table 11: Key Financials of Aspen Pharmacare (in USD Million), 2011-2015
Table 12: Key Financials of Cipla Limited (in USD Million), 2011-2015
Table 13: Key Financials of Sanofi SA (in USD Million), 2011-2015
Table 14: Key Financials of Teva Pharmaceutical (in USD Million), 2011-2015
Table 15: Key Financials of Adcock Ingram (in USD Million), 2011-2015
Table 16: Key Financials of Sun Pharmaceutical (in USD Million), 2011-2015
